Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Treatment with chemotherapy or radiation is not invariably cytotoxic to all tumor cells. Some of the cells that survive treatment recover and resume proliferation, whereas others undergo permanent growth arrest. To understand the nature of treatment-induced terminal growth arrest, colon carcinoma cells were exposed to doxorubicin, and surviving cells were separated into proliferating and growth-arrested populations. Only growth-arrested cells displayed phenotypic markers of cell senescence and failed to form colonies. Gene expression was compared between senescent and proliferating fractions of drug-treated cells by using cDNA microarray hybridization and reverse transcription–PCR. Drug-induced senescence was associated with inhibition of genes involved in cell proliferation and with coinduction of multiple intracellular and secreted growth inhibitors. Several tumor suppressors and other genes that are down-regulated in carcinogenesis were up-regulated in senescent tumor cells. Induction of most growth inhibitors was delayed but not abolished in cells with homozygous knockout of p53, in agreement with only limited p53 dependence of drug-induced terminal growth arrest. On the other hand, senescent cells overexpressed secreted proteins with antiapoptotic, mitogenic, and angiogenic activities, suggesting that drug-induced senescence is associated with paracrine tumor-promoting effects. About one-third of the genes up-regulated in senescent cells and almost all of the down-regulated genes showed decreased or delayed changes in p21 Waf1/Cip1/Sdi1 -deficient cells, indicating that p21 is a major mediator of the effects of p53 on gene expression. Elucidation of molecular changes in tumor cells that undergo drug-induced senescence suggests potential strategies for diagnostics and therapeutic modulation of this antiproliferative response in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many types of cytotoxic chemotherapies are severe DNA-damaging agents that can induce senescence in both tumor cells and surrounding normal cells (31–34).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Senescent cells acquire many changes in gene expression, mostly documented as altered mRNA abundance, including increased expression of secreted proteins [ 33 – 41 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
Self-citationMitotic Misregulation and Human Aging
Ly, D. H., Lockhart, D. J., Lerner, R. A., & Schultz, P. G. (2000) · Science · doi:10.1126/science.287.5462.2486 · Cited by 599
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
Research works printed but not linked: 6
- B D Chang, E V Broude, M Dokmanovic, H Zhu, A Ruth, Y Xuan, E S Kandel, E Lausch, K Christov, I B Roninson Cancer Res 59, 3761–3767 (1999).
- J Campisi In Vivo (Athens, Greece) 14, 183–188 (2000).
- M A Jordan, K Wendell, S Gardiner, W B Derry, H Copp, L Wilson Cancer Res 56, 816–825 (1996).
- S K Myohanen, S B Baylin, J G Herman Cancer Res 58, 591–593 (1998).
- T Waldman, K W Kinzler, B Vogelstein Cancer Res 55, 5187–5190 (1995).
- Dotto, G. P. (2000) Biochim. Biophys. Acta 1471, M43-M56.
Cited by
Items 101–200 of 365
Čekan, P., Hasegawa, K., Pan, Y., Tubman, E. S., Odde, D. J., Chen, J.-Q., Herrmann, M. A., Kumar, S., & Kaláb, P. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0025 · Cited by 66
MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells
He, X., Yang, A., McDonald, D. G., Riemer, E. C., Vanek, K. N., Schulte, B. A., & Wang, G. Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19267 · Cited by 64
Zhang, Y., Gao, Y., Zhang, G., Huang, S., Dong, Z., Kong, C., Su, D., Du, J., Zhu, S., Liang, Q., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25365 · Cited by 64
Alao, J. P., & Sunnerhagen, P. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-51 · Cited by 65
Mallory, J. C., Crudden, G., Oliva, A., Saunders, C. P., Stromberg, A. J., & Craven, R. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016519 · Cited by 65
Yu, X., Liu, Y., Yin, L., Peng, Y., Peng, Y., Gao, Y., Yuan, B., Zhu, Q., Cao, T., Xie, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0460-4 · Cited by 63
Ma, K., Xu, Q., Wang, S., Zhang, W., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.045 · Cited by 62
Bientinesi, E., Lulli, M., Becatti, M., Ristori, S., Margheri, F., & Monti, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111689 · Cited by 61
Breast cancer revisited using DNA array‐based gene expression profiling
Bertucci, F., Viens, P., Hingamp, P., Nasser, V., Houlgatte, R., & Birnbaum, D. (2002) · International Journal of Cancer · doi:10.1002/ijc.10867 · Cited by 61
El‐Far, A. H., Darwish, N. H. E., & Mousa, S. A. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735419901160 · Cited by 60
Cozzi, S.-J., Parsons, P. G., Ogbourne, S. M., Pedley, J., & Boyle, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0348 · Cited by 60
Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers
Bell, R., Barraclough, R., & Vasieva, O. (2017) · Current Molecular Medicine · doi:10.2174/1566524017666170807144946 · Cited by 60
Multiple facets of p53 in senescence induction and maintenance
Johmura, Y., & Nakanishi, M. (2016) · Cancer Science · doi:10.1111/cas.13060 · Cited by 59
Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
Kallenbach, J., Roozbahani, G. A., Horestani, M. H., & Baniahmad, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00941-0 · Cited by 59
Petty, R., Kerr, K. M., Murray, G. I., Nicolson, M. C., Rooney, P. H., Bissett, D., & Collie-Duguid, E. S. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3399 · Cited by 58
A chemotherapy-associated senescence bystander effect in breast cancer cells
Di, X., Bright, A. T., Bellott, R., Gaskins, E., Robert, J., Holt, S., Gewirtz, D. A., & Elmore, L. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5861 · Cited by 57
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro
Prencipe, M., Fitzpatrick, P., Gorman, S., Mosetto, M., Klinger, R., Furlong, F. M., Harrison, M. J., O’Connor, D. P., Roninson, I. B., O’Sullivan, J. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605419 · Cited by 57
Self-citationSadaie, M., Dillon, C., Narita, M., Young, A. R. J., Cairney, C. J., Godwin, L. S., Torrance, C. J., Bennett, D. C., Keith, W. N., & Narita, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0003 · Cited by 57
Brouwers, B. A. H., Hatse, S., Lago, L. D., Neven, P., Vuylsteke, P., Dalmasso, B., Debrock, G., den Bulck, H. V., Smeets, A., Bechter, O. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8796 · Cited by 59
Kim, K.-H., Park, B., Rhee, D.-K., & Pyo, S. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500341z · Cited by 56
Litwiniec, A., Gackowska, L., Helmin-Basa, A., Żuryń, A., & Grzanka, A. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-9 · Cited by 55
Zheng, K., Ma, J., Wang, Y., He, Z., & Deng, K. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901231 · Cited by 55
Lipid Players of Cellular Senescence
Millner, A., & Atilla-Gokcumen, G. E. (2020) · Metabolites · doi:10.3390/metabo10090339 · Cited by 55
Roth, J., Akalu, A., Zelmanovich, A., Policarpio, D., Ng, B., MacDonald, S., Formenti, S. C., Liebes, L., & Brooks, P. C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62310-3 · Cited by 55
Zheng, X. S., Chu, F., Mirkin, B. L., Sudha, T., Mousa, S. A., & Rebbaa, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.027 · Cited by 55
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
Lafontaine, J., Cardin, G. B., Malaquin, N., Boisvert, J.-S., Rodier, F., & Wong, P. (2021) · Cancers · doi:10.3390/cancers13030386 · Cited by 54
Wideł, M., Lalik, A., Krzywon, A., Poleszczuk, J., Fujarewicz, K., & Rzeszowska‐Wolny, J. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.06.003 · Cited by 53
Shen, M., Luo, Y., Niu, Y., Chen, L., Yuan, X., Goltzman, D., Chen, N., & Miao, D. (2013) · Bone · doi:10.1016/j.bone.2013.04.015 · Cited by 53
Self-citationCellular quiescence caused by the Mdm2 inhibitor Nutlin-3A
Korotchkina, L. G., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10121 · Cited by 53
Hallmarks for senescence in carcinogenesis: novel signaling players
Caino, M. C., Meshki, J., & Kazanietz, M. G. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0316-z · Cited by 54
Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells.
Zhang, L., Sharma, S. P., Zhu, L., Kogai, T., Hershman, J. M., Brent, G. A., Dubinett, S. M., & Huang, M. (2003) · PubMed · Cited by 52
Litwiniec, A., Grzanka, A., Helmin–Basa, A., Gackowska, L., & Grzanka, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0711-4 · Cited by 50
Centella asiatica extracts modulate hydrogen peroxide-induced senescence in human dermal fibroblasts
Kim, Y., Cha, H. J., Nam, K. H., Yoon, Y., Lee, H., & An, S. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01388.x · Cited by 50
Wollmann, W., Goodman, M. L., Bhat‐Nakshatri, P., Kishimoto, H., Goulet, R. J., Mehrotra, S., Morimiya, A., Badve, S., & Nakshatri, H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi031 · Cited by 50
Sp1 transcription factor as a target for anthracyclines: Effects on gene transcription
Mansilla, S., & Portugal, J. (2008) · Biochimie · doi:10.1016/j.biochi.2007.12.008 · Cited by 50
Roscovitine Modulates DNA Repair and Senescence: Implications for Combination Chemotherapy
Crescenzi, E., Palumbo, G. A., & Brady, H. J. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1042 · Cited by 50
Taschner‐Mandl, S., Schwarz, M., Blaha, J., Kauer, M. O., Kromp, F., Frank, N., Rifatbegovic, F., Weiss, T., Ladenstein, R. L., HOHENEGGER, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6527 · Cited by 49
Lee, T., Paola, D. D., Malina, A., Mills, J. R., Kreps, A., Große, F., Tang, H., Zannis‐Hadjopoulos, M., Larsson, O. S., & Pelletier, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568535 · Cited by 50
Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo
Ewald, J. A., Desotelle, J. A., Almassi, N., & Jarrard, D. F. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604288 · Cited by 48
Wang, X., Li, N., Li, H., Liu, B., Qiu, J., Chen, T., & Cao, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0879 · Cited by 48
Bhonde, M. R., Hanski, M.-L., Notter, M., Gillissen, B. F., Daniel, P. T., Zeitz, M., & Hanski, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209017 · Cited by 47
“For example, in 41% of breast carcinomas, the DNA damage induced senescence (te Poele et al., 2002), suggesting an association with a terminal cell cycle arrest (Chang et al., 2002).”
BackgroundResultBhatia, B., Multani, A. S., Patrawala, L., Chen, X., Calhoun‐Davis, T., Zhou, J., Schroeder, L., Schneider‐Broussard, R., Shen, J., Pathak, S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23222 · Cited by 47
“Drug-induced, senescent tumor cells overexpress secreted proteins with anti-apoptotic, mitogenic, and angiogenic activities.(21) Ionizing radiation-induced senescence-like fibroblasts significantly perturb the mammary stromal microenvironment facilitating breast tumor development.”
BackgroundSeresht, H. R., Albadry, B. J., Al-mosawi, A. K. M., Gholami, O., & Cheshomi, H. (2019) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-019-01961-w · Cited by 47
Replicative senescence and senescence-like state induced in cancer-derived cells
Hwang, E. S. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00102-1 · Cited by 47
Molecular chaperones regulate p53 and suppress senescence programs
Sherman, M. Y., Gabai, V. L., O’Callaghan-Sunol, C., & Yaglom, J. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.036 · Cited by 46
Ramalingam, V., Revathidevi, S., Krishnamoorthy, V., Ravikumar, V., & Rajaram, R. (2016) · Tumor Biology · doi:10.1007/s13277-016-4947-8 · Cited by 46
Kuba, A., & Raida, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/9451950 · Cited by 45
Role of senescence induction in cancer treatment
Qin, S., Schulte, B. A., & Wang, G. Y. (2018) · World Journal of Clinical Oncology · doi:10.5306/wjco.v9.i8.180 · Cited by 45
Mountzios, G., Dimopoulos, M. A., Soria, J., Sanoudou, D., & PAPADIMITRIOU, C. A. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.10.002 · Cited by 46
Are aging biomarkers clinically relevant in oncogeriatrics?
Falandry, C., Gilson, É., & Rudolph, K. L. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.08.004 · Cited by 44
Induction of senescence‐associated growth inhibitors in the tumor‐suppressive function of retinoids
Roninson, I. B., & Dokmanovic, M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10320 · Cited by 44
Self-citationVítovcová, B., Skarková, V., Rudolf, K., & Rudolf, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155324 · Cited by 44
Rodríguez, R., Hansen, L. T., Phear, G. A., Scorah, J., Spang‐Thomsen, M., Cox, A., Helleday, T., & Meuth, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0274 · Cited by 43
Fischer, C. A., Jung, M. K., Zlobec, I., Green, E., Storck, C. A., Tornillo, L., Lugli, A., Wolfensberger, M., & Terracciano, L. (2011) · Head & Neck · doi:10.1002/hed.21440 · Cited by 44
Yan, L., Donze, J. R., & Liu, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208250 · Cited by 43
Iosef, C., Vilk, G. J. A., Gkourasas, T., Lee, K. J., Chen, B. P. C., Fu, P., Bach, L. A., Lajoie, G., Gupta, M. B., Li, S. S. ‐., et al. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.02.006 · Cited by 42
Tumor p53 status and response to topoisomerase II inhibitors
Valkov, N. I., & Sullivan, D. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00143-7 · Cited by 42
Targeting senescence pathways to reverse drug resistance in cancer
Rebbaa, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.011 · Cited by 42
El‐Far, A. H., Godugu, K., Noreldin, A. E., Saddiq, A. A., Almaghrabi, O. A., Jaouni, S. K. A., & Mousa, S. A. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211035450 · Cited by 42
Chen, W.-S., Yu, Y.-C., Lee, Y., Chen, J.-H., Hsu, H.-Y., & Chiu, S.-J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.013 · Cited by 41
Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea
Narath, R., Ambros, I. M., Kowalska, A., Bozsaky, E., Boukamp, P., & Ambros, P. F. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20393 · Cited by 41
Chen, Y., Dokmanovic, M., Stein, W. D., Ardecky, R., & Roninson, I. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0581 · Cited by 41
Self-citationInsights into the role of senescence in tumor dormancy: mechanisms and applications
DeLuca, V. J., & Saleh, T. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10082-6 · Cited by 41
Saleh, T., Alhesa, A., Al-Balas, M., Abuelaish, O. M., Mansour, A. T., Awad, H., El‐Sadoni, M., Carpenter, V. J., & Azab, B. (2021) · Bioscience Reports · doi:10.1042/bsr20210079 · Cited by 40
Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts
Micutkova, L., Diener, T., Li, C., Rogowska-Wrzesinska, A., Mueck, C., Huetter, E., Weinberger, B., Grubeck-Loebenstein, B., Roepstorff, P., Zeng, R., et al. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.07.005 · Cited by 39
From fever to immunity: A new role for IGFBP‐6?
Liso, A., Capitanio, N., Gerli, R., & Conese, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13738 · Cited by 39
α-Sulfoquinovosylmonoacylglycerol Is a Novel Potent Radiosensitizer Targeting Tumor Angiogenesis
Sakimoto, I., Ohta, K., Yamazaki, T., Ohtani, S., Sahara, H., Sugawara, F., Sakaguchi, K., & Miura, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2209 · Cited by 39
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 38
Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
van Schaik, T., Chen, K., & Shah, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678562 · Cited by 38
Cellular senescence in oral cancer and precancer and treatment implications: A review
Campo, J., Cano‐Sánchez, J., Palacios-Sánchez, B., Llamas-Martínez, S., Muzio, L. L., & Martínez, A. B. (2008) · Acta Oncologica · doi:10.1080/02841860802183612 · Cited by 37
Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
Vaish, V., Kim, J., & Shim, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18391 · Cited by 37
Zhang, J., Ying, K., Xiao, Z., Zhou, B., Huang, Q., Wu, H., Yin, M., Xie, Y., Mao, Y., & Rui, Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.11405 · Cited by 37
Meijer, D., Jansen, M. P. H. M., Look, M. P., Ruigrok-Ritstier, K., van Staveren, I. L., Sieuwerts, A. M., van Agthoven, T., Foekens, J. A., Dorssers, L. C. J., & Berns, E. M. J. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9934-3 · Cited by 36
Chojak, R., Fares, J., Petrosyan, E., & Lesniak, M. S. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04387-3 · Cited by 35
The significance of the senescence pathway in breast cancer progression
Pare, R. B., Yang, T., Shin, J., & Lee, C. S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201081 · Cited by 34
The Use of DNA Microarrays to Investigate the Pharmacogenomics of Drug Response in Living Systems
Villeneuve, D. J., & Parissenti, A. M. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387610 · Cited by 34
Mansilla, S., Bataller, M., & Portugal, J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.027 · Cited by 34
Chang, Y., Lee, H., Liu, S.-T., Lin, Y., Chen, T., Hsieh, T., Huang, H., & Huang, S.-M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.006 · Cited by 34
Regulation of cellular senescence by Rb2/p130
Helmbold, H., Deppert, W., & Bohn, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209613 · Cited by 33
Association between diabetes, obesity, aging, and cancer: review of recent literature
Qiang, J. K., Lipscombe, L. L., & Lega, I. C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.14 · Cited by 33
Larsson, O. S., Schéele, C., Liang, Z., Moll, J., Karlsson, C., & Wahlestedt, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1872 · Cited by 32
Crescenzi, E., Raia, Z., Pacifico, F., Mellone, S., Moscato, F., Palumbo, G. A., & Leonardi, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435149 · Cited by 32
Yao, G., Yang, J., Li, Q., Zhang, Y., Qi, M., Fan, S., Hayashi, T., Tashiro, S., Onodera, S., & Ikejima, T. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.8 · Cited by 31
Doxorubicin-induced cell death requires cathepsin B in HeLa cells
Bien, S., Rimmbach, C., Neumann, H., Niessen, J., Reimer, E. N., Ritter, C. A., Rosskopf, D., Činátl, J., Michaelis, M., Schroeder, H. W. S., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.036 · Cited by 31
Radiation-induced skin reactions: oxidative damage mechanism and antioxidant protection
Liu, C., Wei, J., Wang, X., Zhao, Q., Lv, J., Tan, Z., Xin, Y., & Jiang, X. M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1480571 · Cited by 31
Retinoic acid induces CDK inhibitors and growth arrest specific (Gas) genes in neural crest cells
Wang, L., Mear, J. P., Kuan, C.-Y., & Colbert, M. C. (2005) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2005.00788.x · Cited by 31
The impact of cellular senescence in cancer therapy: is it true or not?
Zhang, Y., & Yang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.108 · Cited by 32
The Death Effector Domains of Caspase-8 Induce Terminal Differentiation
Mielgo, A., Torres, V. A., Schmid, M. C., Graf, R. P., Zeitlin, S. G., Lee, P., Shields, D. J., Barbero, S., Jamora, C., & Stupack, D. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007879 · Cited by 30
Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells
Bataller, M., Méndez, C., Salas, J. A., & Portugal, J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0420 · Cited by 30
Autophagy and PTEN in DNA damage-induced senescence
Sharma, A., & Almasan, A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.006 · Cited by 29
Alunno, A., Bistoni, O., Manetti, M., Cafaro, G., Valentini, V., Bartoloni, E., Gerli, R., & Liso, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00554 · Cited by 28
Basu, D., Reyes‐Múgica, M., & Rebbaa, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052188 · Cited by 27
Sung, J. Y., Kim, S. G., Kim, J.-R., & Choi, H. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239976 · Cited by 27
Jee, H. J., Kim, H.-J., Kim, A. J., Song, N., Kim, M., & Yun, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.083 · Cited by 27
Senescence and senolysis in cancer: The latest findings
Imawari, Y., & Nakanishi, M. (2024) · Cancer Science · doi:10.1111/cas.16184 · Cited by 26
Castro, M. E., Guijarro, M. V., Moneo, V., & Carnero, A. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20079 · Cited by 26
Leu, S. J., Sung, J.-S., Chen, M., Chen, C., Cheng, J., WANG, T., & Wang, J. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24557 · Cited by 24
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53
Mann, K., & Hainaut, P. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208563 · Cited by 24
Chao, S. K., Lin, J., Brouwer‐Visser, J., Smith, A. B., Horwitz, S. B., & McDaid, H. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016962108 · Cited by 23
Kellers, F., Fernandez, A., Konukiewitz, B., Schindeldecker, M., Tagscherer, K. E., Heintz, A., Jesinghaus, M., Roth, W., & Foersch, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.865230 · Cited by 23
Metadata
- Authors
- Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Roninson, Igor B.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 99
- Issue
- 1
- Pages
- 389-394
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117570
- OpenAlex
- W2162118018
- Cited by
- 312
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 10 · 2014: 6 · 2013: 13 · 2012: 16
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37ca040333-15)
- National Cancer Institute (R37 CA 40333, R01CA089636, R01CA062099)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK0773909)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- drug-induced senescence, doxorubicin, colon cancer cells, p53, tumor suppressor, growth inhibitors, anti-apoptotic factors, angiogenic factors, chemoresistance, gene expression profiling
- MeSH terms
- Animals, Antineoplastic Agents, Cell Division, Doxorubicin, Humans, Neoplasms, Phenotype, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Down-Regulation, Up-Regulation, Genes, p53, Proto-Oncogene Proteins p21(ras), Cellular Senescence, DNA, Complementary, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.